December 23, 2025

A Tale of Two Economies, GLP-1 Gains & Zero-Gravity Data Centers 12/23/25

Third quarter growth was much stronger than expected, but low consumer confidence paints a mixed picture. Novo Nordisk shares climb after the FDA approves the first GLP-1 obesity pill. Plus, could space be the place for data centers?

Also available on Apple Podcasts ↗